Inanovate is a medical device-diagnostics company headquartered in Sioux Falls, South Dakota with engineering and device production operation in Chapel Hill, North Carolina. Inanovate has developed a breakthrough proteomics platform technology (Bio-ID800/LAS) with an initial diagnostic test application focused on tick born disease. Lyme disease has increasingly become a significant health problem, with early and accurate diagnosis continuing to be a challenge. The Inanovate diagnostic test aims to become a one-stop shop for diagnosis and treatment monitoring.